This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hanukoglu, A. Articles by Daneman, D. Search for Related Content PubMed PubMed Citation Articles by Hanukoglu, A. Articles by Daneman, D.

Relationship of Etiology to Treatment in Congenital Hypothyroidism

Division of Endocrinology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada M5G 1X8; and Department of Pediatrics, E. Wolfson Medical Center and Tel-Aviv University Sackler School of Medicine, Tel-Aviv, Israel 69978

Address all correspondence and requests for reprints to: Dr. Denis Daneman, Division of Endocrinology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8. E-mail: denis.daneman{at}sickkids.on.ca

We examined the patterns of TSH, T₄, and treatment schedules from diagnosis to 4 yr of age in 125 children (50 males anf 75 females) with congenital hypothyroidism (CH). Subjects were divided into 3 groups based on their thyroid scans: 1) athyreosis (n = 31), 2) dysgenesis (n = 54; 49 lingual and 5 hypoplastic), and 3) dyshormonogenesis (n = 40). Follow-up evaluation was carried out at 2–4 wk and 3, 6, 9, 12, 24, 36, and 48 months of age. Median gestational age, age at onset of therapy, and starting L-T₄ dose were similar in the three groups. In infants with athyreosis median screening TSH levels were higher (P < 0.02) and confirmatory T₄ levels were lower than in the other two groups (P < 0.01 vs. dysgenetic; P < 0.05 vs. dyshormonogenetic CH). During the first 6 months of therapy, mean TSH levels were highest in the athyrotic group, intermediate in the dysgenetic group, and lowest in the dyshormonogenetic group. In children with athyreosis, TSH levels normalized by 12 months of age. At 12 months dysgenetic patients had the highest TSH levels (P < 0.05). During the entire study period, TSH levels were lowest in patients with dyshormonogenesis (except at 48 months) and normalized earlier. Mean T₄ levels normalized by 2–4 weeks in all groups. At 3 and 6 months, the percentage of patients who required dose changes was highest in the athyrotic group, and at 12 months it was highest in the dysgenetic group. The athyrotic group received the highest dose of L-T₄, and dyshormonogenetic group received the lowest dose. We conclude that treatment and follow-up schedules for CH may differ in the three etiological categories based on the different hormonal patterns and responses to therapy. Children with athyreosis need close monitoring particularly early in life, whereas those with dysgenesis and dyshormonogenesis require more attention later in life.

This article has been cited by other articles:

				R. Iranpour, M. Hashemipour, M. Amini, S. M. Talaei, R. Kelishadi, S. Hovsepian, S. Haghighi, and Kh. Khatibi [Tc]-99m Thyroid Scintigraphy in Congenital Hypothyroidism Screening Program J Trop Pediatr, December 1, 2006; 52(6): 411 - 415. [Abstract] [Full Text] [PDF]

				M. J. E. Kempers, A. S. P. van Trotsenburg, D. A. van Tijn, E. Bakker, B. M. Wiedijk, E. Endert, J. J. M. de Vijlder, and T. Vulsma Disturbance of the Fetal Thyroid Hormone State Has Long-Term Consequences for Treatment of Thyroidal and Central Congenital Hypothyroidism J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4094 - 4100. [Abstract] [Full Text] [PDF]

				D. Eugene, A. Djemli, and G. Van Vliet Sexual Dimorphism of Thyroid Function in Newborns with Congenital Hypothyroidism J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2696 - 2700. [Abstract] [Full Text] [PDF]

				H. Ohnishi, H. Sato, H. Noda, H. Inomata, and N. Sasaki Color Doppler Ultrasonography: Diagnosis of Ectopic Thyroid Gland in Patients with Congenital Hypothyroidism Caused by Thyroid Dysgenesis J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5145 - 5149. [Abstract] [Full Text] [PDF]

				G. Van Vliet, B. Larroque, L. Bubuteishvili, K. Supernant, and J. Leger Sex-Specific Impact of Congenital Hypothyroidism due to Thyroid Dysgenesis on Skeletal Maturation in Term Newborns J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2009 - 2013. [Abstract] [Full Text] [PDF]